22 Sep 2015

4st Scientific and Industrial Committee

September the 22th, 2015, many Clinical Research players attended the 4th edition of the Scientific and Industrial Committee of ACCELENCE which was held at the IHU LIRYC in Pessac.

During this meeting, opened by Professor Nicholas MOORE, Chairman of ACCELENCE and by Mr. VIGOUROUX, CEO of University Hospital of Bordeaux, 28 representatives of the health Industry (Pharmaceutical companies, medical device manufacturers, CRO), 21 key opinion leaders from a large spectrum of disease areas, as well as numerous institutions partners have discussed about issues on ” the innovation coming from the hospital toward a market.

Also, this Council was higjlighted by the signing of a Partnership Agreement with Novartis and by the renewal of the Prime Site Partnership with Quintiles.

Download the 4th Scientific and Industrial Committee presentations :

Pr. Alain TAIEB, Head of the Dermatology Unit at the Bordeaux University Hospital and Mr. Jean-Jacques VOISARD, Head of PIERRE FABRE DERMATOLOGY : Hemangiol Project – The Story of a Perfect Partnership Public-Private

Pr. Noël MILPIED, Head of the Hematology and Cell Therapy at the Bordeaux University Hospital and Mr. Pierre-Noël LIRSAC, Chairman of CELLforCURE : C4C Project

Pr. Nicholas MOORE, Chairman of Accelence : ACCELENCE’s Update and Perspectives

Mr. Janos FILAKOVSZKY, Vice-President, Head of EMEA Sites Management QUINTILES : Quintiles – Celebrating Success in Bordeaux








Mot clés : ,